{"name":"Arch Biopartners","slug":"arch-biopartners","ticker":"ARCH.V","exchange":"TSXV","domain":"archbiopartners.com","description":"Arch Biopartners Inc., together with its subsidiaries, engages in the development of novel drugs for acute kidney injury and organ damage in Canada. It focuses on developing its lead drug candidate LSALT Peptide, which is in Phase 2 trials to treat inflammation related acute kidney injury experienced by patients undergoing on-pump (bypass) cardiac surgery; and cilastatin to prevent toxin related acute kidney injury via dipeptidase-1. The company also develops CKD Platform, therapeutics targeting chronic kidney disease. Arch Biopartners Inc. is based in Toronto, Canada.","hq":"Toronto, Ontario, Canada","founded":0,"employees":"","ceo":"","sector":"Anti-Infective / Organ Protection","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0.43,"stockChange":0,"stockChangePercent":0,"marketCap":"$21M","metrics":{"revenue":115184.3423895,"revenueGrowth":0,"grossMargin":-284.9,"rdSpend":0,"netIncome":-1964312.7768615,"cash":3033.3720315,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"yahoo_finance","revenue":0,"revenuePeriod":"2025-09-30","revenueHistory":[{"period":"2025-09-30","value":0},{"period":"2024-09-30","value":0},{"period":"2023-09-30","value":0},{"period":"2022-09-30","value":0}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":-6935.295459,"rdSpendHistory":[{"period":"2025-09-30","value":-6935.295459},{"period":"2024-09-30","value":2656217.4321465},{"period":"2023-09-30","value":1413957.2250075},{"period":"2022-09-30","value":926913.386448}],"sgaSpend":835751.922393,"operatingIncome":-904748.5668885,"operatingIncomeHistory":[{"period":"2025-09-30","value":-904748.5668885},{"period":"2024-09-30","value":-2592338.1001125},{"period":"2023-09-30","value":-2183197.9297605},{"period":"2022-09-30","value":-786965.856816}],"netIncome":-1131407.691972,"netIncomeHistory":[{"period":"2025-09-30","value":-1131407.691972},{"period":"2024-09-30","value":-2856519.811344},{"period":"2023-09-30","value":-2424022.020564},{"period":"2022-09-30","value":-1025835.7069785}],"eps":-0.024,"epsHistory":[{"period":"2025-09-30","value":-0.024},{"period":"2024-09-30","value":-0.062},{"period":"2023-09-30","value":-0.053},{"period":"2022-09-30","value":-0.023}],"cash":1531.623351,"cashHistory":[{"period":"2025-09-30","value":1531.623351},{"period":"2024-09-30","value":2164.091985},{"period":"2023-09-30","value":605707.4870864999},{"period":"2022-09-30","value":368950.723374}],"totalAssets":76165.836765,"totalLiabilities":2904448.983933,"totalDebt":1818025.9878795,"equity":-2828283.1471679998,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":-1154244.3272925,"dividendsPaid":null,"buybacks":null,"employees":0,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":677441.6715105,"ebit":-1074194.7833625,"ebitda":-1074194.7833625,"period":"2025-12-31","revenue":0,"epsBasic":-0.024,"netIncome":-1136243.01669,"rdExpense":344814.1755615,"epsDiluted":-0.024,"grossProfit":null,"operatingIncome":-1078433.343321},{"sga":218472.73671599998,"ebit":-151174.576536,"ebitda":-151174.576536,"period":"2025-09-30","revenue":0,"epsBasic":null,"netIncome":-196559.301579,"rdExpense":-206576.0600025,"epsDiluted":null,"grossProfit":null,"operatingIncome":-158055.2232075},{"sga":165339.542256,"ebit":-133678.22073,"ebitda":-133678.22073,"period":"2025-06-30","revenue":0,"epsBasic":-0.004,"netIncome":-176576.790267,"rdExpense":65773.09468349999,"epsDiluted":-0.004,"grossProfit":null,"operatingIncome":-157719.315327},{"sga":265703.862126,"ebit":-406245.970566,"ebitda":-406245.970566,"period":"2025-03-31","revenue":0,"epsBasic":-0.009,"netIncome":-454935.1256265,"rdExpense":76898.1305175,"epsDiluted":-0.009,"grossProfit":null,"operatingIncome":-379733.293473},{"sga":186237.9672465,"ebit":-252222.37057499998,"ebitda":-252222.37057499998,"period":"2024-12-31","revenue":0,"epsBasic":-0.006,"netIncome":-303337.93180049997,"rdExpense":56969.5393425,"epsDiluted":-0.006,"grossProfit":null,"operatingIncome":-209243.649483},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":0.43,"previousClose":0.43,"fiftyTwoWeekHigh":1.95,"fiftyTwoWeekLow":0.39,"fiftyTwoWeekRange":"0.39 - 1.95","fiftyDayAverage":0.55,"twoHundredDayAverage":1.08,"beta":2.05,"enterpriseValue":22887199.293297,"forwardPE":0,"priceToBook":-7.96,"priceToSales":184.79,"enterpriseToRevenue":198.7,"enterpriseToEbitda":0,"pegRatio":0,"ebitda":0,"ebitdaMargin":0,"freeCashflow":-554752.228971,"operatingCashflow":-1115539.141383,"totalDebt":1918713.099921,"debtToEquity":0,"currentRatio":0.01,"returnOnAssets":-524,"returnOnEquity":0,"analystRating":"","recommendationKey":"none","numberOfAnalysts":0,"targetMeanPrice":0,"targetHighPrice":0,"targetLowPrice":0,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":968803200,"insiderHeldPercent":19.2,"institutionHeldPercent":0,"sharesOutstanding":67933289,"floatShares":52329115,"sharesShort":27106,"shortRatio":0.3,"shortPercentOfFloat":0,"epsTrailing":-0.04,"epsForward":0,"revenuePerShare":0,"bookValue":-0.05,"officers":[{"age":54,"name":"Mr. Richard Gabriel Muruve","title":"Co-Founder, CEO, President & Director"},{"age":null,"name":"Dr. Daniel Abraham Muruve M.D.","title":"Co-Founder, Chief Science Officer & Member of Scientific Advisory Board"},{"age":59,"name":"Mr. Andrew  Bishop CFA","title":"CFO & Director"},{"age":null,"name":"Dr. Justin  MacDonald Ph.D.","title":"Co-Founder & Principal Scientist"},{"age":null,"name":"Dr. Paul  Beck","title":"Co-Founder & Principal Scientist"},{"age":null,"name":"Mr. Aaron  Benson","title":"Director of Communications & Clinical Data Management"}],"industry":"Biotechnology","irWebsite":"","website":"https://www.archbiopartners.com","phone":"647-428-7031"}}